about
New vaccines: challenges of discoveryMicroRNA-1299 is a negative regulator of STAT3 in colon cancerThe Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic ApproachesRNA metabolism in neurodegenerative disease.The Emerging Role of Epigenetics in Autoimmune Thyroid Diseases.Identification and characterization of RNA aptamers: A long aptamer blocks the AMPA receptor and a short aptamer blocks both AMPA and kainate receptors.Advances in the delivery of RNA therapeutics: from concept to clinical reality.Small Interfering RNA Targeting Mitochondrial Calcium Uniporter Improves Cardiomyocyte Cell Viability in Hypoxia/Reoxygenation Injury by Reducing Calcium Overload.Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2Hepatic porphyria: A narrative review.Lessons from Enzyme Kinetics Reveal Specificity Principles for RNA-Guided Nucleases in RNA Interference and CRISPR-Based Genome Editing.The chemical evolution of oligonucleotide therapies of clinical utility.The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications.Human DBR1 modulates the recycling of snRNPs to affect alternative RNA splicing and contributes to the suppression of cancer development.Bioconjugation of Small Molecules to RNA Impedes Its Recognition by Toll-Like Receptor 7.Nucleic acids: function and potential for abiogenesis.Non-coding RNAs in cardiovascular disease: pathological relevance and emerging role as biomarkers and therapeutics.The emergence of noncoding RNAs as Heracles in autophagy.The functions and unique features of long intergenic non-coding RNA.Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines.Circular RNAs in thoracic diseases.Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.Holistic and Affordable Analyses of MicroRNA Expression Profiles Using Tagged cDNA Libraries and a Multiplex Sequencing Strategy.mRNA vaccines - a new era in vaccinology.Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination.Generation and characterization of aptamers targeting factor XIa.Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer.Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context.Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway.Long non-coding RNAs in ovarian cancer.Structure-activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides.Current Progress in Electrotransfection as a Nonviral Method for Gene DeliveryCircular RNAs as Therapeutic Agents and Targets
P2860
Q26970823-FD552D55-BE49-48F7-91B9-8CF6BB3DE7D6Q33721111-18586ED3-7C9B-47CF-B2B6-5EF192393044Q33735551-8A979ADD-B321-4937-A3B9-6CDB448097C4Q33746283-CA39F300-702D-4D1D-B45F-8A553B15AD46Q37740639-B9FFE880-5AA5-4A93-968E-7527ACF04C32Q38288608-8F91228E-C61F-4DE3-97C7-1BA8712D98B9Q38706445-464072F6-0B3D-46D0-901B-E2B4C8D27C81Q38710888-B4865A7E-F70E-444E-9E12-583C2C5B5D0DQ38789206-435B378B-6DB6-4E04-A9EC-E5D5B6921F5CQ38994896-792EADFE-8001-45BF-8A7D-5800FD1EBCBAQ39105063-CDA56B27-117D-4267-93A3-8A3639125F4BQ39154511-BB3DBF20-6D26-410F-9428-329B0C995906Q39227810-1B02429C-590C-4F74-8BDF-F549A756FA4FQ39297820-E5817AE0-68E6-4900-B4B6-3F02C8CAAE91Q40201325-166456D4-0325-4830-9E53-0A9D4C170877Q40258598-9E1A6710-85D3-4688-AB8D-7CBC22C87787Q46242768-FA5F2058-B959-4E0E-96F4-DE6E889B1343Q46252008-DD781A62-42FB-437A-AB36-0C9D18DCE32BQ46377062-C5BCC970-B820-4942-AD67-C737AA376EB9Q46920734-E707E320-36B2-40B4-BC25-47FC9DFF42C7Q47097938-0DF292DF-DB58-495C-831D-4A505AAA9AFDQ47142027-D0999783-32B5-46E6-BA9B-089847120373Q47220309-93908004-2D40-4946-9AD3-5C48BD094C7BQ47223739-BC7C0D27-D21A-402D-B3F0-DC474566B205Q47680009-CAE14B22-C0CF-49BD-9DC6-845AE17D6013Q47736893-B89B73DF-A0FA-4CF5-A813-DE89B33B5E2DQ50454256-B1AE9451-B0D3-429B-A1B3-12E9E103F82CQ50566748-EE52523A-2D87-44DC-B2DC-3CD9D7476149Q52582168-6324A4BA-9E64-46CE-A24D-430F5EF64327Q52721688-D3EA4967-482D-48E4-B2EB-2D7CEDB80D04Q55269808-9C3860B9-56D2-43DD-AEE1-CFB0CDF369FDQ55315467-7B461A66-2734-49F9-BC92-19A22235E79BQ55379950-A6F02271-1AF9-4269-A21D-1342493A6E64Q57161406-7990F8BC-E607-47D1-BC14-D07E4F6A0619Q57817032-E4A3E736-32C4-4882-B2F5-137C0BAF66F6
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
From the RNA world to the clinic.
@en
type
label
From the RNA world to the clinic.
@en
prefLabel
From the RNA world to the clinic.
@en
P2860
P356
P1433
P1476
From the RNA world to the clinic.
@en
P2093
Bruce A Sullenger
Smita Nair
P2860
P304
P356
10.1126/SCIENCE.AAD8709
P407
P577
2016-06-01T00:00:00Z